Literature DB >> 3928173

Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma.

D L Hoover, C A Nacy, M S Meltzer.   

Abstract

Macrophages are pivotal cells in interactions of man and leishmania. Leishmanial disease results from intracellular infection of macrophages: parasitized cells are seen in smears or biopsy specimens of lesions; macrophages cultured in vitro support replication of parasites. Paradoxically, parasite destruction is also mediated by macrophages, which become highly cytotoxic after exposure to immune lymphocytes or their lymphokine (LK) products. The precise molecular mechanisms by which lymphocytes or LK induce macrophage activation for leishmanicidal activity, however, are not yet known. We analyzed interactions of leishmania amastigotes with human monocytes cultured in vitro as a nonadherent cell pellet. Leishmania donovani and L. major replicated in freshly isolated monocytes. Monocytes treated with greater than 200 IU/ml of the LK, human Interferon-gamma (IFN-gamma), destroyed tumor cells and L. donovani, but not L. major. Phorbol myristate acetate, endotoxic bacterial lipopolysaccharide, and recombinant human IFN-alpha and IFN-beta did not induce cytotoxicity. The time course for induction of cytotoxicity contrasted sharply with that of previously described monocyte antileishmanial activity: IFN-gamma induced cytotoxicity even when added after infection with L. donovani; induction of cytotoxicity did not require that IFN-gamma be present throughout the period of culture after infection: a 30-min preinfection pulse of IFN-gamma was sufficient to induce 70% of maximal activity; and freshly isolated monocytes and cells cultured for up to 4 days in vitro prior to infection and IFN-gamma treatment were equally responsive to IFN-gamma. These studies provide convincing evidence for intracellular cytotoxicity for L. donovani by freshly isolated human monocytes. This system provides an important base for further analysis of induction and expression of cytotoxic mechanisms against leishmania and other intracellular organisms that cause human disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928173     DOI: 10.1016/0008-8749(85)90274-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  Down regulation of macrophage activation in Brugia pahangi-infected jirds (Meriones unguiculatus).

Authors:  C Nasarre; J L Krahenbuhl; T R Klei
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

Authors:  H W Murray; M J Oca; A M Granger; R D Schreiber
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

3.  Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages.

Authors:  C E Luedke; A Cerami
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice.

Authors:  K E Squires; M Kirsch; S C Silverstein; A Acosta; M J McElrath; H W Murray
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

5.  Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.

Authors:  T I Roach; A F Kiderlen; J M Blackwell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient.

Authors:  H Albrecht; H J Stellbrink; G Gross; B Berg; U Helmchen; H Mensing
Journal:  Clin Investig       Date:  1994-12

7.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.

Authors:  M Kemp; J A Kurtzhals; K Bendtzen; L K Poulsen; M B Hansen; D K Koech; A Kharazmi; T G Theander
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

9.  A 25-kilodalton fraction from Mycobacterium tuberculosis that inhibits hexose monophosphate shunt activity, lysozyme release, and H2O2 production: reversal by gamma interferon.

Authors:  A A Wadee; A M Clara
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

10.  Interleukin-3 induces antimicrobial activity against Leishmania amazonensis and Trypanosoma cruzi and tumoricidal activity in human peripheral blood-derived macrophages.

Authors:  J L Ho; S G Reed; J Sobel; S Arruda; S H He; E A Wick; K H Grabstein
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.